CHESTERBROOK, PA — Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System (CNS) conditions, announced that its management team will participate in two upcoming conferences:
- H.C. Wainwright 21st Annual Global Investment Conference, sponsored by H.C. Wainwright, to be held at the Lotte New York Palace Hotel in New York City on Tuesday, September 10, 2019 at 9:35 am ET.Live audio webcast and archived replay of the presentation will be available on Trevena’s investor relations website at https://investors.trevena.com/. Following the conclusion of the presentation, the webcast will be available for replay for 30 days.
- Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Disease Companies, sponsored by Oppenheimer & Co., to be held at the Parker New York Hotel in New York City on Wednesday, September 23 and Thursday, September 24, 2019.
For more information about the conferences, or to schedule a one-on-one meeting with Trevena’s management, please contact KCSA Strategic Communications at [email protected], or send an email to [email protected] (H.C. Wainright), or [email protected] (Oppenheimer & Co.).
Source: Trevena, Inc., 955 Chesterbrook Blvd, Suite 200, Chesterbrook PA 19087
Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.